Cytokinetics | CYTK - Eps Gewinn Pro Aktie

Aktienkurs
75.85
Täglich Wechseln
-2.79 -3.55%
Monatlich
15.94%
Jährlich
144.68%
Q2 Prognose
75.32

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 -1.67 -1.65 -1.36 May/05
FY2025Q4 Dec/2025 -1.50 -1.56 -1.26 Feb/24
FY2025Q3 Sep/2025 -2.55 -1.57 -1.36 Nov/05
FY2025Q2 Jun/2025 -1.12 -1.42 -0.08 Aug/07
FY2025Q1 Mar/2025 -1.36 -1.27 -1.33 May/06




Eps Veränderung Datum
Acadia Pharmaceuticals USD 0.02 1.58 2026-03
Amgen USD 5.15 0.14 2026-03
Arca Biopharma USD -0.54 0.14 2025-12
Bayer EUR 2.71 2.09 2026-03
Biogen USD 3.57 1.58 2026-03
Brainstorm Cell Therapeutics USD -0.19 0.15 2025-09
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Capricor Therapeutics USD -0.62 0.08 2025-12
Cytokinetics USD -1.67 0.17 2026-03
Eisai JPY 60.94 24.92 2025-12
Eli Lilly USD 8.55 1.01 2026-03
Exelixis USD 0.87 0.1 2026-03
Geron USD -0.01 0.04 2026-03
Halozyme Therapeutics USD 1.6 1.84 2026-03
Ionis Pharmaceuticals USD -0.56 0.85 2026-03
Ligand Pharmaceuticals USD 1.63 0.39 2026-03
Merck USD -1.28 3.32 2026-03
Novartis USD 1.99 0.04 2026-03
Pfizer USD 0.75 0.09 2026-03
Regeneron Pharmaceuticals USD 9.47 1.97 2026-03
Roche Holding CHF 8.37 2.95 2025-12
Sanofi EUR 1.88 0.35 2026-03